ARREX
Price
$28.11
Change
+$0.01 (+0.04%)
Updated
Sep 20 closing price
VGSIX
Price
$32.50
Change
-$0.12 (-0.37%)
Updated
Sep 20 closing price
Ad is loading...

ARREX vs VGSIX

Header iconARREX vs VGSIX Comparison
Open Charts ARREX vs VGSIXBanner chart's image
American Century Real Estate R5
Price$28.11
Change+$0.01 (+0.04%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Investor
Price$32.50
Change-$0.12 (-0.37%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ARREX vs VGSIX Comparison Chart
Loading...
VS
ARREX vs. VGSIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARREX is a StrongSell and VGSIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGSIX has more cash in the bank: 70.5B vs. ARREX (744M). VGSIX pays higher dividends than ARREX: VGSIX (3.85) vs ARREX (2.46). ARREX was incepted earlier than VGSIX: ARREX (7 years) vs VGSIX (28 years). ARREX is a more actively managed with annual turnover of: 117.00 vs. VGSIX (9.00). ARREX has a lower initial minimum investment than VGSIX: ARREX (0) vs VGSIX (3000). VGSIX (30.65) and ARREX (29.85) have marching annual gain over last year. VGSIX return over 5 years is better than : 25.45 vs. ARREX (-2.55).
ARREXVGSIXARREX / VGSIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years28 years-
Gain YTD14.24412.979110%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets744M70.5B1%
Annual Yield % from dividends2.463.8564%
Returns for 1 year29.8530.6597%
Returns for 3 years-10.343.36-307%
Returns for 5 years-2.5525.45-10%
Returns for 10 yearsN/A86.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIDU2.750.09
+3.38%
Sidus Space
TUSK3.920.09
+2.35%
Mammoth Energy Services
ADNT22.670.08
+0.35%
Adient plc
NICE164.89-0.94
-0.57%
NICE Ltd
PLRX12.15-0.47
-3.72%
Pliant Therapeutics